Grant: Travel Awards - Institute Community Support
Unity Health Toronto
$1,500.00
Examining Reporting Bias in Randomized Controlled Trials from Two Network Meta-Analyses: Comparison of Clinical Trial Registrations and Their Respective Publications
FY 2018-19
Summary
Network meta-analyses (NMAs) combine results from many studies to help clinicians decide which treatment is best for their patient by considering all interventions and outcomes. As patients may value certain outcomes more than others (quality of life versus additional life years), NMA results can be especially useful for clinicians and patients to collectively decide which treatment is best. The accuracy of NMA results depends on the original studies reporting all treatment harms and benefits. My presentation to a patient-inclusive audience will outline the issues of incomplete reporting of harms and will discuss how NMA authors should address this issue.
Department
Program
Travel Awards - Institute Community Support
Recipient
Location
Ontario, Canada
Recipient Type
Other
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
387884
Name
Lachance Chantelle C
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Health Services and Policy Research
Theme2
Health systems / services
Prcname2
Institute of Health Services and Policy Research
Projecttitle
Examining Reporting Bias in Randomized Controlled Trials from Two Network Meta-Analyses: Comparison of Clinical Trial Registrations and Their Respective Publications
Programtype2
Undefined
Orgnameinp2
Unity Health Toronto
Cihramount2
$1,500
Cihrequipment2
$0
Programname2
Travel Awards - Institute Community Support
Keyworddelim
Ics Travel Awards
Abstract
Network meta-analyses (NMAs) combine results from many studies to help clinicians decide which treatment is best for their patient by considering all interventions and outcomes. As patients may value certain outcomes more than others (quality of life versus additional life years), NMA results can be especially useful for clinicians and patients to collectively decide which treatment is best. The accuracy of NMA results depends on the original studies reporting all treatment harms and benefits. My presentation to a patient-inclusive audience will outline the issues of incomplete reporting of harms and will discuss how NMA authors should address this issue.
Competitiondate
201808
Approvedterm2
1 yr 0 mth
Pinamesdelim
Lachance, Chantelle C
Approvedterm
1 an 0 mois
Cihrcontribution2
Inst of Hlth Serv & Policy Res~ $1,500~ $0~
